JP2007504268A - ヘルペス感染症を処置するための方法および組成物 - Google Patents

ヘルペス感染症を処置するための方法および組成物 Download PDF

Info

Publication number
JP2007504268A
JP2007504268A JP2006526176A JP2006526176A JP2007504268A JP 2007504268 A JP2007504268 A JP 2007504268A JP 2006526176 A JP2006526176 A JP 2006526176A JP 2006526176 A JP2006526176 A JP 2006526176A JP 2007504268 A JP2007504268 A JP 2007504268A
Authority
JP
Japan
Prior art keywords
herpes
composition
mammal
disease
iga
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006526176A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504268A5 (https=
Inventor
ベツ，ウルリヒ
ラトケ，クラウス−ペーター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grifols Therapeutics LLC
Original Assignee
Grifols Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Therapeutics LLC filed Critical Grifols Therapeutics LLC
Publication of JP2007504268A publication Critical patent/JP2007504268A/ja
Publication of JP2007504268A5 publication Critical patent/JP2007504268A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2006526176A 2003-09-05 2004-09-02 ヘルペス感染症を処置するための方法および組成物 Withdrawn JP2007504268A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/656,781 US6984492B2 (en) 2003-09-05 2003-09-05 Methods and compositions for treating herpes infections
PCT/US2004/028559 WO2005025617A2 (en) 2003-09-05 2004-09-02 Methods and compositions for treating herpes infections

Publications (2)

Publication Number Publication Date
JP2007504268A true JP2007504268A (ja) 2007-03-01
JP2007504268A5 JP2007504268A5 (https=) 2007-10-18

Family

ID=34226428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006526176A Withdrawn JP2007504268A (ja) 2003-09-05 2004-09-02 ヘルペス感染症を処置するための方法および組成物

Country Status (13)

Country Link
US (3) US6984492B2 (https=)
EP (1) EP1663309A2 (https=)
JP (1) JP2007504268A (https=)
KR (1) KR20060107509A (https=)
CN (1) CN1845756A (https=)
AU (1) AU2004272001A1 (https=)
BR (1) BRPI0414139A (https=)
CA (1) CA2537360A1 (https=)
IL (1) IL173805A0 (https=)
NO (1) NO20061184L (https=)
NZ (1) NZ546303A (https=)
WO (2) WO2005023303A1 (https=)
ZA (1) ZA200602738B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012526075A (ja) * 2009-05-04 2012-10-25 リボバックス バイオテクノロジーズ ソシエテ アノニム 眼疾患を処置または診断する際に使用するための抗体の抗原結合フラグメント
JP2017520572A (ja) * 2014-06-26 2017-07-27 ハイデルべルク イミュノセラピューティクス ゲーエムベーハー 抗ｈｓｖ抗体の外用適用
JP2022512946A (ja) * 2018-11-08 2022-02-07 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 自己抗体媒介性眼疾患の治療および診断

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013023362A1 (zh) * 2011-08-16 2013-02-21 深圳市卫武光明生物制品有限公司 静注巨细胞病毒人免疫球蛋白及其制备方法
US10829543B2 (en) 2012-10-29 2020-11-10 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
US10100102B2 (en) 2012-10-29 2018-10-16 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
WO2015134368A2 (en) * 2014-03-03 2015-09-11 Albert Einstein College Of Medicine Of Yeshiva University Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
WO2017083681A1 (en) 2015-11-13 2017-05-18 The University Or North Carolina At Chapel Hill Optimized crosslinkers for trapping a target on a substrate
CN105532575A (zh) * 2016-01-14 2016-05-04 中国科学院昆明动物研究所 一种单纯疱疹病毒感染树鼩动物模型的构建、评估方法及其应用
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2021207348A1 (en) * 2020-04-07 2021-10-14 Albert Einstein College Of Medicine Method of treating and preventing ocular disease with hsv-2 delta gd

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717564A (en) * 1985-11-07 1988-01-05 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
RU2051054C1 (ru) 1992-04-14 1995-12-27 Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского Способ получения препарата противогерпетического иммуноглобулина человека
US5681565A (en) * 1993-01-12 1997-10-28 Medical Sciences Research Institute Methods and compositions for passive immunotherapy
WO1994015640A1 (en) * 1993-01-12 1994-07-21 Anthony George Gristina Methods and compositions for the direct concentrated delivery of passive immunity
AU6968098A (en) * 1997-04-15 1998-11-11 Advanced Viral Research Corp. Topical treatment of skin diseases and eye afflictions
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6010041778, Ｂｒｉｔｉｓｈ Ｊｏｕｒｎａｌ ｏｆ Ｏｐｈｔｈａｌｍｏｌｏｇｙ, 1981, ６５, ｐ．３９２−３９５ *
JPN6010041779, Ｊｏｕｒｎａｌ ｏｆ Ｉｎｆｅｃｔｉｏｕｓ Ｄｉｓｅａｓｅｓ, 1994, １６９， ３, ｐ．６４７−６４９ *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012526075A (ja) * 2009-05-04 2012-10-25 リボバックス バイオテクノロジーズ ソシエテ アノニム 眼疾患を処置または診断する際に使用するための抗体の抗原結合フラグメント
JP2017520572A (ja) * 2014-06-26 2017-07-27 ハイデルべルク イミュノセラピューティクス ゲーエムベーハー 抗ｈｓｖ抗体の外用適用
JP2022512946A (ja) * 2018-11-08 2022-02-07 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 自己抗体媒介性眼疾患の治療および診断
JP7624220B2 (ja) 2018-11-08 2025-01-30 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 自己抗体媒介性眼疾患の治療および診断
JP2025061211A (ja) * 2018-11-08 2025-04-10 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 自己抗体媒介性眼疾患の治療および診断

Also Published As

Publication number Publication date
NZ546303A (en) 2009-03-31
US6984492B2 (en) 2006-01-10
KR20060107509A (ko) 2006-10-13
EP1663309A2 (en) 2006-06-07
CA2537360A1 (en) 2005-03-24
BRPI0414139A (pt) 2006-10-31
WO2005025617A3 (en) 2005-05-26
CN1845756A (zh) 2006-10-11
IL173805A0 (en) 2006-07-05
ZA200602738B (en) 2008-06-25
US20060198848A1 (en) 2006-09-07
WO2005025617A2 (en) 2005-03-24
US20050053605A1 (en) 2005-03-10
AU2004272001A1 (en) 2005-03-24
NO20061184L (no) 2006-06-01
US20090232798A1 (en) 2009-09-17
WO2005023303A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
US20090232798A1 (en) Methods and compositions for treating herpes infections
EP2621499B1 (en) Methods for the treatment of allergic diseases
Gariboldi et al. Low dose oral administration of cytokines for treatment of allergic asthma
WO2005067900A3 (en) Azabenzofuran substituted thioureas as inhibitors of viral replication
KR102417080B1 (ko) 신규한 노카르다민의 금속 착물 및 약제 조성물에서의 이의 용도
RU2733432C1 (ru) Лечение вирусного конъюнктивита с применением ранпирназы и/или амфиназы
JPH06507386A (ja) 治療用ペプチド
US20060019987A1 (en) Methods and compositions for inhibiting, destroying, and/or inactivating viruses
WO2019161761A1 (zh) 一种治疗疟疾的药物组合物
CA2251690C (en) New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
US20080306079A1 (en) External preparation for allergic diseases
JP6080479B2 (ja) マイタケ抽出物由来の単純ヘルペスウイルス感染症の予防・治療剤
MXPA06002585A (en) Methods and compositions for treating herpes infections
KR20220033450A (ko) 니클로사마이드를 포함하는 항인플루엔자 바이러스용 조성물
RU2847403C1 (ru) Способ лечения иммунодефицита внутривенным введением аминодигидрофталазиндиона натрия
Nicholson Antiviral Therapy: Respiratory Infections, Genital Herpes, and Herpetic Keratitis
WO2022251824A1 (en) Mmp13 as a therapeutic target for allergic inflammatory diseases
WO2024241250A2 (en) Novel composition for treatment of inflammatory related disorders
WO2001093866A1 (en) Compounds with anti-hsv activity
JP2018070497A (ja) マイタケ抽出物のヘルペス感染症の治療及び／又は予防のための組成物
JPH06135854A (ja) 単純ヘルペスウイルス感染症治療剤
HK1238559A1 (en) New metal complexes of nocardamine and their use in pharmaceutical compositions
WO2007065450A1 (en) Means for preventing and treating conjunctivitis of different ethiology (variants) and a method for the use thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070831

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070831

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20081216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20081216

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20100728

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100803